ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, HSPG2, DCN, HGS, CX3CR1, THBS2, THBS1, E2F2, TGFB2, PLK2, TIE1, KLF4, CXCL10, TEK, PF4]
GO:0036376;sodium ion export across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;131.16583792001737;7.138016298065211;0.004390002553592762;0.7612791106150483;[ATP1B2, ATP1B1, SLC8A1]
GO:1902430;negative regulation of amyloid-beta formation;8.0;1.0;0.875;9.628524252492122;443.73862177950616;7.57984905034425;0.014851532332127743;0.7626338329336335;[CLU]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[NLRP12, NLRP3]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, NOD2, TLR4, MYD88, IL17A]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, BMP2, CD40LG, CSPG4, PKN1]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[LRRK2, EGF, F2R, ADAM9]
GO:0030823;regulation of cGMP metabolic process;9.0;0.7586651285174919;0.775573189439035;9.392135474427892;212.55514157362143;6.444869117505266;0.00711402930126111;0.7258315315665724;[PDE5A, GUCA1C, THBS1]
GO:0048489;synaptic vesicle transport;7.0;0.7671156992804218;0.7344772148974115;9.292052015870908;108.01043080855717;5.459585514144159;0.003615011916085639;0.6301228223472235;[LIN7A, SNCA, SYT2, DNM2]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[NLGN4Y, NLGN1, SYT2, KIAA1109, SNCA]
GO:0030949;positive regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;213.0397923327438;7.069023426578259;0.0071302501260115695;0.7124295520356204;[IL1B, ITGB3]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[, IGHM, C1QA, CR2, CR1, CLU, IGHG1, IGKC, IGLV1-44, TRBC1, IGHD, IGHA1, IGKV3-20]
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;7.474488534686424;0.00995955788091634;0.7331650565203278;[HHEX, HGS, EMILIN1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, AKT1, RAN]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0098735;positive regulation of the force of heart contraction;8.0;1.0;0.875;9.628524252492122;28.25379719464655;8.16763571524637;9.456291653381902E-4;0.7926932703116032;[SLC8A1]
GO:2000473;positive regulation of hematopoietic stem cell migration;8.0;1.0;0.875;9.628524252492122;201.08518903965808;9.083926447120524;0.006730140312236458;0.839552420951524;[PTPRC, CCR2]
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;8.16763571524637;0.0027327542132076126;0.7408135829017477;[CSF1R]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:0002374;cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[NLRP3, NOD2, TLR2]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, HMOX1, SFN, BARD1, LYN, PLK2, PLK1, CDKN1A, CHAF1B, CHAF1A, CTLA4, SIRT1, UNG, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, COPS5, BCL6, CNOT3, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, PPP1R15A, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, SOX4, ESCO2, MIF, EPHA2, POLA1, SUV39H1, BRCA1, BRCA2, RAD51C, SGK1, YAP1, PCNA, RAD54B, RAD54L, RPA1, MLH1, RPA3, DCLRE1A, PSMD14, HMGA1, JMY, TOPBP1, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:1903779;regulation of cardiac conduction;7.0;0.6913464685778243;0.6965925995461126;8.763526815005518;28.828680454715183;5.788089581116195;9.648699906913433E-4;0.6469225356091749;[ATP2A3, SLC8A1, FLNA, CXADR, CAV1, TRPC1, EHD3, FKBP1B]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[DLC1, ARHGAP6, THBS1]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, ITGB3, NCF4, VAV1, NCKAP1L, FYN, MAPK14, PTK2]
GO:2000008;regulation of protein localization to cell surface;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;29.0551629072873;6.166155715036245;9.724501545579579E-4;0.6384578026126634;[TNF, AKT1, FCER1G, EGF, GOPC, CD247]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, NOD2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, GATA3, AKT1, KCNH1, PDGFRB, PDGFRA, GSN]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MEF2C, RUNX2, SPINT1, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, NR4A1, BMP2, ID1, NOX4, SNAI2, NRP1, MCM7, TMEM100, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[NRP1, PDGFRA, CSF1R, TGFB1, F11R, HCK, FES, ARHGDIA, NTF3, ARHGDIB, STAP1, TEK]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD14, CD244, TLR2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[BRCA2, HHEX, SLITRK6, HOXA5, STIL, RMI1, GRHL2, NDUFS6]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[BCL6, DLC1, STMN1, ARAP3]
GO:1903421;regulation of synaptic vesicle recycling;6.0;0.7671156992804218;0.7066781622303554;9.176539128749065;29.360544556841745;6.943860283624253;9.826710035429039E-4;0.6782296504172152;[CYFIP1, NLGN1, LRRK2, SNCA]
GO:1903426;regulation of reactive oxygen species biosynthetic process;6.0;0.7866048967936545;0.7164227609869718;9.223059144383958;42.429949999716015;5.514393750639154;0.0014200922420146414;0.6051266654433651;[ITGB2, TNF, CLU, AKT1, CD36, CD34, DNM2, IFNG, IL1B, TLR6, TLR4, PTGS2, SLC30A10, KLRK1, SNCA, AGXT2, CAV1, KLF4, PTX3]
GO:0002581;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;55.710237364246;8.67846133901236;0.0018645715086227877;0.7669372290569613;[HLA-DOA, HLA-DOB, THBS1]
GO:0071280;cellular response to copper ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.518977089658987;0.0026274528238337297;0.6565011041187423;[AQP1, SNCA]
GO:0071281;cellular response to iron ion;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;78.90930355153202;7.697632086000634;0.002641023376107184;0.7167775754447168;[TF]
GO:1905606;regulation of presynapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.485423408851448;80.99250311658214;8.390779266560578;0.0027107461907915228;0.7800242071602487;[NLGN1, SNCA]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, CLEC4D, CARD11]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, F13A1, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, TLN1, VCL, STXBP2, PDGFA, THBS1, PSAP, FLNA, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, TGFA, PDGFA, AURKB, FGF5, LBH, RACGAP1, PDGFD, NUP62, PDGFC, ECT2, SVIL, TGFB2, TGFB1, TAS2R13, CDC6, PPBP, CIT, EREG, BTC, IL1B]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, AQP1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, JUN, TGFB1, FN1, CDC6, MIF, EREG, BTC, CCNA2, NDUFS4]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, ECT2, MYH10, CEP55, PLK1, CKAP2, CIT]
GO:0098719;sodium ion import across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;255.84958837647977;7.069023426578259;0.008563055473280314;0.757750811958709;[SLC8A1]
GO:0048260;positive regulation of receptor-mediated endocytosis;8.0;0.811012628672052;0.780506314336026;9.34084218004034;175.1727623766804;5.8650506222523235;0.005862874711496551;0.6749389615747303;[FMR1, SERPINE1, CLU, RAB21, NTF3, CCL19, SYK, CCL21, EGF, SELE, DNM2, SFRP4, TF]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[CDKN1A, PID1, ITGAM, ITGB2, TNF, CLU, AKT1, CD36, CD177, PDGFRB, PRKCD, DNM2, IFNG, IL1B, AGTR1, TLR6, TLR4, FPR2, PTGS2, THBS1, GNAI2, KLRK1, SNCA, TGFB1, AGXT2, MAPK14, KLF4, NOX4, PTX3]
GO:0051788;response to misfolded protein;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.958124258549983;7.8311634786251565;8.018568580216882E-4;0.6907270763441554;[CLU]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, TLR8, TLR7, MYD88, HAVCR2]
GO:0036344;platelet morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;47.452274261266446;9.083926447120524;0.0015881849152503491;0.7876727335416686;[C1GALT1C1, ACTN1]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[TRPC3, PTGS2, SLC8A1, P2RX5, SELL, P2RX1, IL1B]
GO:0033197;response to vitamin E;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;57.68202331572161;7.292166977892469;0.00193056540992653;0.7238411236270654;[ALAD, COL1A1, ARG1, FKBP1B]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, TNF, LGALS3, AKT1, DAPK1, SFRP2, IL1B, CX3CR1, YAP1, IFI6, THBS1, HMOX1, FYN, TNFRSF10B, SNAI2, PF4]
GO:0060683;regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling;7.0;1.0;0.8509193652572005;9.628524252492122;114.97156652450842;9.777073627680469;0.003847994863883116;0.8509193652572005;[PDGFA]
GO:0006883;cellular sodium ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;285.76071857591336;6.8867018697843045;0.009564154082785858;0.7484268790654467;[ATP1B2, ATP1B1, SLC8A1]
GO:0006644;phospholipid metabolic process;5.0;0.5326392268888578;0.5565606253053492;7.595602726447178;99.62941633188608;3.7463883674192062;0.003334506903974791;0.4818314871956144;[SLA2, EREG, BTC, PDGFA, PLA2G7, CD19, INPP5D, PLCG1, ICOS, CD28, SLC44A5, SLC44A1, IMPA2, GAB1, VAV1, KIT, HBEGF, SGMS1, PNPLA8, KITLG, LPCAT2, NDUFAB1, PNPLA6, CD86, CD80, FGF5, ABHD12, PDGFRB, PDGFRA, TTC7B, CSF1R, RARRES3, SRD5A3, BMX, SERINC5, LCK, AGPAT3, FYN, SNCA, TRAT1, EGF, MBOAT7, MBOAT2]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, PDGFA, FPR2, GNS, S100A12, NCKAP1L, ELANE, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, CCL8, TTR, CCL5, PCDH7, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, CCR1, PRG2, NBEAL2, PPBP, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, STX11, PAK1, CXCR1, CXCR2, CD58, CCT8, LHFPL2, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, APLP2, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MYH10, MGAM, TGFB2, TGFB1, SYT2, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:1902998;positive regulation of neurofibrillary tangle assembly;7.0;1.0;0.8509193652572005;9.628524252492122;133.0039630895162;9.777073627680469;0.004451522948810635;0.8509193652572005;[CLU]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[TFRC, ABCB6, SLC40A1, HEPH, HMOX1, SLC11A1, CYBRD1, TF, LCN2, LTF, ABCG2]
GO:0006638;neutral lipid metabolic process;5.0;0.7140352122741334;0.6472586179979869;8.874752450115741;40.65859522084085;5.266214121163619;0.0013608065916814918;0.5595554469212292;[SLC22A4, MOGAT2, ABHD12, NKX2-3, SNCA, DGAT2, ACSL1, CAV1, DGKZ, SIRT1, FABP7]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[ACE, SYK, PDGFA, RAD50, GPNMB, PDGFD, PDGFC]
GO:0048680;positive regulation of axon regeneration;11.0;0.7866048967936545;0.8257314007264895;9.463444502132672;877.6189055867065;7.9853141584524145;0.02937311496425057;0.8407982897480031;[FKBP1B]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, E2F7]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PYCARD, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, AZU1, DEFA1, CXCL10, IL6, PTPRC, SERINC5, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, IFNG, TLR8, TLR7, UNC93B1, SAMHD1, CARD9, LILRB1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, KCND2, SIRT1, CCNA2, TWIST1, PTGS2, E2F1, HMOX1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, LAT]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, BMP2, LTF]
GO:0060431;primary lung bud formation;8.0;1.0;0.875;9.628524252492122;121.16230854056519;9.083926447120524;0.0040551934278544415;0.839552420951524;[HHEX]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[FCER1G, GATA3, CLEC4D, IL18R1]
GO:0002053;positive regulation of mesenchymal cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;64.15119587261817;6.444869117505266;0.002147082793528545;0.6527112189764278;[PRRX1, PDGFA]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, CALCRL, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ITGB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, SNCA, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[SERPINA1, CTSZ, TGFA, F5]
GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity;11.0;1.0;0.9324289523296623;9.628524252492122;2557.621706734507;7.379178354882098;0.08560129681430756;0.8098004765652196;[FKBP1B]
GO:0032914;positive regulation of transforming growth factor beta1 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.62186638127122;7.9853141584524145;0.0028656868131042177;0.7592887026755414;[LUM, THBS1]
GO:1905908;positive regulation of amyloid fibril formation;7.0;1.0;0.8509193652572005;9.628524252492122;262.5761532817171;8.390779266560578;0.00878818754714322;0.7800242071602487;[CLU]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[, PROS1, NRBP1, COPB2, TGFA, SPTA1, SERPINA1, CTSZ, SPTAN1, TMED6, F5, RAB33B, GOPC]
GO:1905907;negative regulation of amyloid fibril formation;7.0;1.0;0.8509193652572005;9.628524252492122;263.1725048245012;8.390779266560578;0.00880814689659866;0.7800242071602487;[CLU]
GO:0048333;mesodermal cell differentiation;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;21.066225782797595;7.138016298065211;7.050676185779127E-4;0.6150384854347593;[ITGB4, ITGB3, INHBA]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[IGFBP5, PTAFR, AQP9, SLC8A1, AQP1, KCNQ1, NOX4, SLC26A3, CFTR]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, PYCARD, STAP1, CCL2, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, EPB41L3, FLNA, TSPAN5, JUP, TSPAN15, EHD3, RAMP1]
GO:0051612;negative regulation of serotonin uptake;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;189.71062538080213;8.67846133901236;0.006349443903017236;0.8188169164668168;[SNCA]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;10.0;0.811012628672052;0.8207473261969463;9.483342242647623;1661.590298646008;5.192106149009898;0.055611931961498426;0.6807655617789147;[LRRK2, CLU, AKT1, CBFA2T3, RNF144B, EGF, PLK2, CAV1, PLK1, PTK2, CCDC22]
GO:0090197;positive regulation of chemokine secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;759.1048076819071;7.292166977892469;0.025406554763140368;0.7881627702307852;[PYCARD, CSF1R]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[THBS1, HSPD1, HSPE1]
GO:1904715;negative regulation of chaperone-mediated autophagy;8.0;1.0;0.875;9.628524252492122;775.6380740464814;8.67846133901236;0.025959908309388966;0.8188169164668168;[SNCA]
GO:0045199;maintenance of epithelial cell apical/basal polarity;6.0;1.0;0.8231203125901445;9.628524252492122;34.60247581110787;7.138016298065211;0.001158113725191344;0.6881587980249038;[LIN7A]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[TLR8, TLR7]
GO:2001027;negative regulation of endothelial cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;484.3135532944439;8.390779266560578;0.016209538774865105;0.8443458537639685;[CXCL13, THBS1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0051622;negative regulation of norepinephrine uptake;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;44.494875090957315;9.777073627680469;0.0014892034265065574;0.8231203125901445;[SNCA]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0035050;embryonic heart tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;7.004484905440688;0.0011047978665365144;0.6484506956670166;[HHEX]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:1900127;positive regulation of hyaluronan biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;589.7686013946351;8.390779266560578;0.019739024331396862;0.8253454670833372;[EGF, NFKB1]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[, SCARB2, CYP1B1, ACSL1, ACSL5, MIF, POR, SLC27A3, SLC27A2, MGST1, ACAT1, PRKAR2B, CYP4F2, CYP4F3, CYP4F12, TBXAS1, TECR, ETFA, BRCA1, GHR, ACADM, HIBCH, ELOVL4, CYP4A11, ELOVL6, ELOVL7, NDUFS6, EHHADH, ACSBG1, HSD17B4, PTGS2, CYP3A4, PTGS1, ALOX5, SNCA, PNPLA8, MAPK14, SCD, NDUFAB1, PLP1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ATP1B1, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, VDR, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, CD24, GPR18, CXCL9, CD40, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL23, CCL21, TMEM64, GPR6, P2RX5, CD4, FKBP1B, GRINA, F2RL3]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[MAP2K2, EGF, IQGAP3, TNFSF11, CTSH]
GO:0002027;regulation of heart rate;7.0;0.7043150770688792;0.7030769037916401;8.712233520617966;26.867502833526505;5.233778845410465;8.992311406554274E-4;0.6185750588070984;[CALCA, KCNE3, KCNA5, SLC8A1, PLN, DMD, DSP, KCNH2, JUP, GCH1, CAV1, TPM1, TACR3, AVPR1A, MC3R, KCNQ1, FKBP1B]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[TLR4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, S100A12, CD14, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, DUSP10, TIMP3, CSK, EMILIN1, LYN, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;238.42697029648212;8.67846133901236;0.007979936125481077;0.8188169164668168;[STMN1, SNCA]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[CCL13, CD40, ADAMTS12, PYCARD, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, KMO, NFKB1, CHI3L1, XCL1, RBMX, IL17A]
GO:0071103;DNA conformation change;5.0;0.6729672293956388;0.6267246265587396;8.242229891372231;21.24116723228514;5.058574756385375;7.10922751455178E-4;0.5489367601502517;[SMARCAL1, MCM7, NCAPG2, HMGB2, SMC4, SMC2, HHEX, RUVBL2, RUVBL1, ANXA1, MCM4, MCM6, MCM2, BLM, CDCA5, RAD54B, RAD54L, HMGA1, RPA1, RAD50, RAD51, ACIN1, NCAPD2, NCAPD3]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[NLRP3, TREM2, NOD2]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, DAPK1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0042416;dopamine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;507.8534772351106;7.474488534686424;0.01699739884460309;0.7572456912631272;[NR4A2, TGFB2, GPR37, GCH1, SNCA]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, SELP, GH1, KIT, CD28, PTPN6, TEK]
GO:0061179;negative regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1298.6518127055795;7.57984905034425;0.04346470746050344;0.8200627852632958;[FKBP1B]
GO:1903361;protein localization to basolateral plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;65.42666064804821;7.8311634786251565;0.002189771451718415;0.7236063770733796;[CAV1, LIN7A]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, TNF, CLU, SIRPB1, PYCARD, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, SFRP4, IL1B, NLGN1, CD151, LRP1, DLL1, RAB21, NTF3, STAP1, CCL2, NCKAP1L, CCL19, CD14, SNCA, CCL21, EGF, AZU1, SELE, TF, PTX3, FCGR2B]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, GATA3, LYN, ABCA1, COL1A1, MMP12, CENPF, GOPC, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, TNFSF13B, ITGB6, LCP2, LRP1, LRP2, GOLPH3L, ACTN4, MSR1, EGR2, POLA2, TF, CD24, CD3G, CCR7, CD36, SYK, HSD17B4, STX11, FKBP1B, RAMP1, SCARB2, CARD11, ECT2, NUP155, NASP, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, NUP35, RAN, PHB2, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, CCL19, TNF, CLU, LAMP2, RAB32, CALCRL, SLC15A3, BCL6, CCDC22, NLGN1, UNC93B1, NLRC4, NOD2, RAB21, VPS41, IL1RN, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, CD40LG, NUPL2, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, GH1, IL6, IFNG, KIT]
GO:0042775;mitochondrial ATP synthesis coupled electron transport;7.0;1.0;0.8509193652572005;9.628524252492122;33.34232067890278;7.57984905034425;0.0011159374669824286;0.738553198190834;[NDUFB6, SNCA]
GO:0045920;negative regulation of exocytosis;8.0;0.7140352122741334;0.7320176061370667;9.004369943419128;172.2069348332117;6.375876246018314;0.005763611132688151;0.701062607729944;[ANXA1, FMR1, GNAI2, RAB33B, CEACAM1, HMOX1, FCGR2B, IL13RA2, CCR2, SNCA]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, AZU1, TLR4, THBS1, CCR2]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, HSPD1, MMP12, TLR8, TLR7, TLR4]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, TNR, DCC, SIRT1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, BCL6, SIPA1]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[DOCK5, NRP1, CYR61, EMILIN2, CCR7, EMILIN1, CD36, OLFM4, DNM2, CCDC80, MMRN1, CEACAM6, NINJ1, COL8A1, EPB41L5, FLNA, JUP, CCL21, FN1, TEK]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, AZU1, MIF, ADCYAP1, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, GPNMB, CD34, HAVCR2, GHSR, LILRB1, IRAK3, BPI, TLR4, GPR18]
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;424.7653704329427;6.943860283624253;0.014216514684375884;0.7703503496879909;[MAL, TIMP3, THBS1, ATF3]
GO:0038027;apolipoprotein A-I-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;8.16763571524637;8.87013979980389E-4;0.7408135829017477;[ABCA1, ITGB3]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[SFRP4, SYK, EGF, FMR1, NTF3, SELE]
GO:0038145;macrophage colony-stimulating factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.67846133901236;0.00101047745553359;0.7947362817240173;[CSF1R]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, GP1BA, PALLD, COL6A3, YAP1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, BLM, MGST1, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, CD3G, CD3E, CD3D, ALAD, EMILIN1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0021940;positive regulation of cerebellar granule cell precursor proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;202.6652060662171;9.083926447120524;0.006783022060192384;0.8154717862087246;[EGF]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, PDGFD, HMOX1, ECT2, JUN, KLF4, COL1A1, IL6, NR4A3, FKBP1B, SDC1, EZH2]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, GHSR, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[CYFIP1, CELSR1, F11R, CTGF, PYCARD, EPS8, ARHGDIA, STMN1, ARHGDIB, ARFIP1, PDGFRB, PDGFRA, MEF2C, TPM1, PRKCD, PFN1, EPHA3, CSF1R, TACSTD2, PDGFA, CORO1A, SPTA1, STAP1, NCKAP1L, VASP, TGFB1, BST1, CXCL12, FES, JMY, ID1, NOX4, NRP1, LMOD1, ARHGEF10L, ARHGAP6, CCR7, SPTAN1, RHOG, RHOH, ARAP1, CIT, HCK, TMEFF2, RHOU, SHANK3, LRP1, SYNPO2, PAK1, NTF3, EPS8L1, FLNA, JAM3, GSN, CCL21, DLC1, TEK]
GO:0010944;negative regulation of transcription by competitive promoter binding;11.0;1.0;0.9324289523296623;9.628524252492122;1584.3015218227836;7.57984905034425;0.053025146156608326;0.8200627852632958;[HHEX, DACH1]
GO:0051131;chaperone-mediated protein complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;6.8867018697843045;0.0014899461700306506;0.6753065664753021;[CCT2, CLU, HOPX, HSPD1]
GO:0010820;positive regulation of T cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1408.745447987039;7.379178354882098;0.04714944235553481;0.8098004765652196;[TNFSF14, CCL5, XCL1, CXCL13, CCR2]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, NCKAP1L, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:0016486;peptide hormone processing;7.0;0.7980440201809971;0.7499413753476991;9.328419660041783;182.775265034119;6.280566066213989;0.006117323633632836;0.6721078059595746;[ENPEP, ACE, MME, CTSZ, PCSK6, CTSG]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[CALCRL, LRP1, TFRC, ITGB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, CD9, RAMP1]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CDA, TCL1A, TNFSF11, MCCC2, MIF, CLDN3, MGST1, ACMSD, CD79B, CD79A, HMOX1, VASP, JUP, COL1A1, EHD3, COL1A2, CD3G, CD3E, CD3D, FCER1G, KCND2, ARG1, KCNA5, GCH1, GOPC, KCNG2, CHRNB4, OLFM4, BLM, ACAT1, NACC2, NLRP3, ECT2, CAV2, CAV1, TNFAIP3, ALAD, NUP62, EMILIN1, ADSL, VWF, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, NLRC4, NOD2, SAMHD1, PLN, CCL5, RRM1, MARCKS, RAD51, P2RX1, IMPDH2, TEK, CD247, RBMX]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, EPS8, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, FZD8, GH1, BMP2, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, GHR, MAP4K1, SYK, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:0014048;regulation of glutamate secretion;8.0;0.811012628672052;0.780506314336026;9.485423408851448;84.2585196773718;6.8867018697843045;0.0028200568258570785;0.7271862538851576;[IL1RN, IL1B, AVPR1A, KMO, SNCA]
GO:0051271;negative regulation of cellular component movement;5.0;0.5470854108181258;0.5637837172699831;7.364160372318274;52.38761662992485;4.128099389519264;0.001753366382809582;0.5013522066171892;[SEMA5B, IL1RN, SERPINE1, SPINT2, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, ACTN1, TPM1, ACTN4, MIF, SFRP2, PADI2, VCL, KCNE3, TACSTD2, FBLN1, GATA3, PKHD1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, GPR18, NRP1, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TGFBR3, TMEFF2, ENG, CX3CR1, LRP1, THBS1, SPOCK3, CCL2, CCL21, SEMA4B, TIE1, PODN, KLF4, DLC1, CD9]
GO:0051272;positive regulation of cellular component movement;5.0;0.5452700253111464;0.5628760245164934;7.377232453885626;52.22589589123734;3.603287523778533;0.0017479537352249267;0.4745133033969606;[SPARC, SERPINE1, MYLK, LGALS3, STMN1, C3AR1, AKT1, IL1R1, ACTN4, CLDN7, PFN1, TWIST1, PDGFA, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, TACR3, SIRT1, F3, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, IGFBP5, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, BCL6, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, CD40, PRL, BRCA1, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, TNF, AQP1, ALAD, GHSR, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, ALPL, SDC1]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[PTPRR, CUL5, EGF, GAB1, EREG, BTC, HBEGF]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, TNFAIP3, BRCA1, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0014059;regulation of dopamine secretion;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;80.46310298086182;6.444869117505266;0.0026930276446781535;0.7045909063862833;[CXCL12, CNR1, SNCA]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, CD14, TLR2]
GO:0045715;negative regulation of low-density lipoprotein particle receptor biosynthetic process;8.0;1.0;0.875;9.628524252492122;494.7516452988549;8.67846133901236;0.016558892320579825;0.8188169164668168;[ITGB3]
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.67846133901236;0.013811191226989502;0.8919372290569614;[TLR1, CD14, TLR2]
GO:0002076;osteoblast development;4.0;1.0;0.75;9.628524252492122;32.15320660831846;6.832634648514029;0.001076138889173156;0.5994212536750128;[CLEC5A, HOXA2, RUNX2, MEN1]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, TRPC1, F2R, CXCL10, CXCL11, JPH2, CD19, XCL1, PLCG1, F2RL3, SNCA]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, CD40, PTGS2, THBS1, AKT1, HMOX1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, PLK1, AZU1, CHI3L1]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[IGHM, CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CLU, CXCL5, S100A12, CTSG, IGHA1, ELANE, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, PPBP, LYZ, CXCL10, CXCL11, SLPI, LCN2, PRTN3, BPI, IGKV3-20, S100A8, LTF, PF4]
GO:0030510;regulation of BMP signaling pathway;11.0;0.7508913569872202;0.8078746308232723;9.360260265897443;322.7842812572362;5.334422371190153;0.010803299406686577;0.705231560468336;[LRP2, PCSK6, CYR61, ZNF423, FZD1, SFRP4, SFRP2, ENG]
GO:0030511;positive regulation of transforming growth factor beta receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;345.4564576873422;6.518977089658987;0.011562116748168153;0.7083807915285978;[MYOCD, TGFB1I1, THBS1, TGFBR3, LRG1, MEN1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[TAF9, MIF, SIRT1, CLU, CXCL12, SFRP2, SNAI2]
GO:0022604;regulation of cell morphogenesis;5.0;0.5326392268888578;0.5565606253053492;7.3549266963713285;31.055921926933518;3.6012063575747084;0.001039413758379302;0.47440687246051283;[CYFIP1, SPARC, CPNE5, EPS8, DPYSL2, ACTN4, MAP1B, SDC2, EPB41L3, FN1, PTK2, ID1, ROBO2, NRP1, ARHGAP4, ANXA1, RHOG, RHOH, HCK, KIT, RHOU, CCL13, FGD3, FGD4, PAK1, PDPN, FLNA, DLC1, SEMA5B, PLXND1, FMR1, MPL, ARHGDIA, TNR, TPM1, VRK1, OLFM4, CSF1R, TACSTD2, FBLN1, ARHGAP15, CORO1A, SPTA1, MYH14, MYH10, SYT2, CXCL12, FES, PLXNB2, DOCK5, LRRK2, ITGB2, YWHAH, DCC, ARAP3, ARAP1, DNM2, FGR, ITGA7, SHANK3, NLGN1, RAB21, CCL7, CCL2, FYN, WASF3, LINGO1, SEMA4B]
GO:0021879;forebrain neuron differentiation;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;26.729186262933762;7.069023426578259;8.946018095145202E-4;0.6846304993685643;[CSF1R, BCL11B, INHBA, SHANK3]
GO:1901387;positive regulation of voltage-gated calcium channel activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;1442.0152551110536;7.474488534686424;0.0482629528590931;0.8146746435927894;[EHD3, KCNE3]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[PLAU, PROS1, SERPINE1, GP1BA]
GO:0061017;hepatoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;47.57053087451796;9.083926447120524;0.0015921428576718348;0.7547934328124444;[HHEX]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[SLC8A1, CTGF, LGALS1, SOX4, MEN1, RMI1, PAX2, IL1B, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, FKBP1B, NOX4]
GO:0032769;negative regulation of monooxygenase activity;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;96.37597526722934;7.379178354882098;0.003225617159447592;0.7004918368257019;[CNR1, CAV1, NFKB1, SNCA]
GO:0048169;regulation of long-term neuronal synaptic plasticity;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;42.75619717690252;6.481236761676141;0.0014310114414316764;0.7276913745807394;[GRM5, KIT, SHANK3, SNCA]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, PTPN6]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, GATA3, APCDD1, FZD1, FZD5, FZD8, NR4A2, VANGL1, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, CD36, CCR2, HAVCR2, FCER1G, MIF, TLR1, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A2, SLC24A1, NLGN1, PLK2, TNR, SHANK3, SNCA]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MEF2C, JUN]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ACTN1, PTPRK, SORBS1, ARHGAP6, DLC1]
GO:0032764;negative regulation of mast cell cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;9.083926447120524;0.010410680043746014;0.839552420951524;[BCL6, HMOX1]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[PKHD1, EHD3, ABLIM3, FLNA, GSN]
GO:1903573;negative regulation of response to endoplasmic reticulum stress;7.0;0.7671156992804218;0.7344772148974115;9.136047767394327;87.05963143969353;6.015873511986907;0.0029138075157050677;0.6585714164269392;[PPP1R15A, LRRK2, CLU, WFS1, GRINA]
GO:1902004;positive regulation of amyloid-beta formation;8.0;1.0;0.875;9.628524252492122;442.71613466832366;7.474488534686424;0.01481731060869512;0.7572456912631272;[CLU]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, CD4]
GO:1904307;response to desipramine;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;62.210167333483;9.777073627680469;0.0020821183151359633;0.7902410118609202;[SNCA]
GO:0032515;negative regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1090.4524045737035;5.788089581116195;0.03649646063763195;0.7112441822128948;[PPP1R15A, TNF, GNAI2, NCKAP1L, FKBP1B]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, S1PR3, ZNF423, TGFB1, JAG1, KRT19, BMP2, SNAI2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, CXCL10, MYD88, CIITA, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, BRCA1, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, RGMA, IL1B, KIT, YAP1, IL17A, CD86, CD80, ACTG2, CCNE1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, ACTA2, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0010748;negative regulation of plasma membrane long-chain fatty acid transport;9.0;1.0;0.896240625180289;9.628524252492122;652.3932031735304;8.390779266560578;0.02183501339445399;0.8253454670833372;[AKT1, THBS1]
GO:0010621;negative regulation of transcription by transcription factor localization;11.0;0.9326813400603323;0.8987696223598284;9.604426700913061;1614.1306916489104;8.67846133901236;0.05402350162617884;0.8762458687964789;[HHEX, ID1]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0010745;negative regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;114.21841186311113;7.212124270218933;0.0038227874551613377;0.6919486831672181;[ABCA1, NFKBIA, NR1H2, ITGB3]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, CD36, IL6R, FCER1G, F2R, EREG, TLR1, ADCYAP1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, CARD9, LILRB2, IL6, MYD88, IL17A]
GO:0033603;positive regulation of dopamine secretion;9.0;1.0;0.896240625180289;9.628524252492122;382.96729536294987;7.9853141584524145;0.01281757072760856;0.8046099625986299;[CXCL12]
GO:0048294;negative regulation of isotype switching to IgE isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1408.9297354134765;8.67846133901236;0.047155610289849756;0.8762458687964789;[BCL6]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, PRG2, GATA3, CD3E, CD40LG, CD28, NLRP3, PRKCQ, HAVCR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, PDGFA, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, F3, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, IGFBP5, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0032754;positive regulation of interleukin-5 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[NLRP3, GATA3, IL17RB]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:1903464;negative regulation of mitotic cell cycle DNA replication;11.0;0.8933024483968273;0.8790801765280758;9.57973408832269;1479.2060550404028;9.083926447120524;0.049507695463181504;0.8969813732811862;[BCL6]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUN, IGFBP5, DUSP1, FOS, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, TEK, SLC26A3, CFTR]
GO:1903588;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;10.0;1.0;0.9152410118609203;9.628524252492122;357.96927251473664;8.390779266560578;0.011980909399638815;0.8443458537639685;[THBS1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, CLU, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, SERINC5, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, CHUK, IFNGR1, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0051585;negative regulation of dopamine uptake involved in synaptic transmission;9.0;0.9326813400603323;0.8625812952104552;9.601125278304007;543.5031361224321;9.777073627680469;0.01819056084495172;0.896240625180289;[SNCA]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SERPINE1, SLA2, PHB2, STMN1, AKT1, UBASH3A, PRKACB, DAPK1, PRKCD, PADI2, PRKCQ, ATF3, GATA3, ADAMTS12, FLRT2, FIGNL1, PRDM16, HMOX1, LYN, FZD1, SNAI2, EZH2, TGFB1I1, LRRC4, TIMP2, TIMP3, DUSP2, DUSP1, ARG1, FCRL3, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, NR1H2, TMEM64, SULF2, LGR4, PF4, TNF, CLU, PYCARD, RUVBL2, MEN1, TLE4, IGFBP5, CSF1R, LY96, FOXO1, WFS1, TNFRSF10B, PTPRE, CXCL12, PTPRC, BCL6, CCDC22, LRRK2, FASLG, PTPN22, HHEX, LBH, DUSP10, EMILIN1, PVRIG, CX3CR1, PPP1R15A, LRP1, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, KLF4, PTPN6, IL1RN, LGALS3, PPP2R1A, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, SIK1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, CD14, EGR1, LIF, VNN1, NRP1, PTPRR, ECM1, BRCA1, CD3E, RHOH, GP1BA, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, GNAI2, PODN, NLRP12, KIF26A, DLC1, FKBP1B, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, NDUFS3, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, THBS1, SNCA, EGF, MAPK14, TEK]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C1QA, PROS1, C5AR1, CLU, IGHG1, IGKC, CD19, IGLV1-44, C3AR1, CR2, CR1, IGKV3-20]
GO:0051583;dopamine uptake involved in synaptic transmission;9.0;1.0;0.896240625180289;9.628524252492122;254.03495274861447;7.9853141584524145;0.0085023212518817;0.8046099625986299;[SNCA]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, NAIP, SFN, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, SERPINA1, TIMP2, TIMP3, TIMP1, CR1, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, LTF, SERPINB10, IFI6, NLRC4, PTGS2, THBS1, SPOCK3, SNCA, KLF4]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, GATA3, CDH3, FRZB, SOX4, FZD1, FZD5, EGF, FZD8, TMEM64, KLF4, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, SNAI2, LGR4]
GO:0032743;positive regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.409777797693995;0.002183412136085803;0.6509166472493662;[CD86, CD83, CD80, CD3E, PDE4B, CCR2, ANXA1, CD4, IL1B, CD28, PRKCQ, CARD11]
GO:1905892;negative regulation of cellular response to thapsigargin;5.0;1.0;0.7902410118609202;9.628524252492122;80.06386528339098;9.777073627680469;0.002679665518234405;0.7902410118609202;[CLU]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MEF2A, MEF2C, PADI4, ATF3, GATA3, JUN, HACE1, NR2F2, EZH2, HOXC10, CHAF1B, FOS, SIRT1, STAT4, FLNA, ZNF467, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, CIITA, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, UXT, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, DEPDC1, LOXL2, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, TAF5, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, TFDP1, SMARCD3, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, KLF4, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, C5AR1, NLRP3, CBX4, NR4A2, CREBZF, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:1905895;negative regulation of cellular response to tunicamycin;5.0;1.0;0.7902410118609202;9.628524252492122;80.06386528339098;9.777073627680469;0.002679665518234405;0.7902410118609202;[CLU]
GO:1903238;positive regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;440.9461040801303;8.390779266560578;0.014758069277832396;0.8443458537639685;[ITGA4, PTAFR, ELANE, CCR2]
GO:0051481;negative regulation of cytosolic calcium ion concentration;11.0;0.9326813400603323;0.8987696223598284;9.57973408832269;290.3013502407617;7.004484905440688;0.00971612493830514;0.7906386361357586;[KCNA5, SLC8A1]
GO:1903237;negative regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;459.0491676986248;8.390779266560578;0.015363962525443897;0.8443458537639685;[CXCL12, CCL21]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL3]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, MAPK14, TNF, OSCAR, TNFSF11, EPHA2]
GO:0032736;positive regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.069023426578259;0.002183412136085803;0.6846304993685643;[NLRP3, GATA3, IL17RB]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL21, CCL20, PPBP, CXCL10, CXCL11, CXCL12, XCL1, PF4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, HSPD1, PYCARD, CD40LG, CD28, XCL1, TLR4, CD34, TLR2]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0030031;cell projection assembly;4.0;0.6729672293956388;0.5864836146978194;8.124446855715847;35.515967283127445;3.9749552523034066;0.0011886874626708887;0.45327939645711923;[CYFIP1, MYLK, VCL, PDGFA, PKHD1, NUP85, NCKAP1L, MYH10, EHD3, NRP1, RAC2, EMP1, KIT, RHOU, FGD3, FGD4, ABLIM3, FLNA, WASF3, SH2B1, GSN, CCL21, KLF5, PMP22]
GO:0007250;activation of NF-kappaB-inducing kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1337.9940718610228;6.8867018697843045;0.04478145746870162;0.8003065664753022;[CHI3L1, TNFRSF10B, TLR6]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, THBS1, CLDN4, TLR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, CD19, FYN, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0008344;adult locomotory behavior;3.0;0.8436909121759173;0.6199657686781032;9.158520623246385;24.575257889458463;5.459585514144159;8.225117652639858E-4;0.47732376968016754;[ABHD12, CHL1, SLITRK6, DRD4, SCN1A, SNCA, NR4A2, CXCL12]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, S100A12, TGFB1, NFKB1, MYD88, CD40, ITGB2, CD36, CHUK, IRAK3, TRAF1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[LYN, PRL, GHR, GH1, STAT4, CCL2, CCR2]
GO:0001942;hair follicle development;4.0;1.0;0.75;9.628524252492122;22.36266381479647;6.166155715036245;7.48458232790436E-4;0.5653374900225189;[TGFB2, PDGFA, INHBA, CELSR1, APCDD1, LGR4]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[PDGFRA, TPM1, MSH2, TWIST1, GATA3, EPB41L5, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, RGMA, IL1B, YAP1, IL17A, CD86, CD80, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, IFNA2, PRL, RHOG, MDFIC, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, GATA3, XCL1, TLR4, HAVCR2]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, PLK1, COL1A1, NUP35, RAN]
GO:0031115;negative regulation of microtubule polymerization;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;405.4514152206468;7.292166977892469;0.013570093984851534;0.7881627702307852;[STMN1, SNCA]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, MIF, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, MIS12, CCT8, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, TTC19, TEK, CDA, BIN2, NUP205, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, BRD2, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, NACC2, LSM3, HOPX, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, AXIN2, DNM2, TGFBR3, COLEC12, HIST1H2BK, HSPD1, REPS2, RBMX]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, ARHGAP4, EPS8, PAK1, ARHGDIA, PDPN, ARHGDIB, RAC2, EPS8L1, CHUK, RHOG, RHOH, COL1A2, BCL6, AGTR1, RHOU]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0007269;neurotransmitter secretion;8.0;0.7043150770688792;0.7271575385344395;8.771074020640901;61.60461712537578;6.113511981550823;0.00206185109463042;0.6876452870438905;[SLC5A7, LIN7A]
GO:0014909;smooth muscle cell migration;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;22.014357120524497;7.474488534686424;7.368007211888268E-4;0.7053660038532718;[PDGFRB, PLAU, ITGB3]
GO:0035705;T-helper 17 cell chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;128.70806217747682;9.777073627680469;0.004307743011344492;0.9152410118609203;[CCR2]
GO:0001953;negative regulation of cell-matrix adhesion;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;66.9585131603638;6.280566066213989;0.002241041176727861;0.6721078059595746;[JAG1, SERPINE1, ARHGAP6, THBS1, BCL6, DLC1, HOXA7]
GO:0001956;positive regulation of neurotransmitter secretion;8.0;0.7508913569872202;0.7504456784936101;9.33127272902419;367.30173324646773;7.069023426578259;0.012293258461660482;0.7365101867784198;[NLGN1, KMO, SNCA]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, IFI6, SFN, CLU]
GO:0010544;negative regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.593432932680852;379.9001511686048;6.8867018697843045;0.012714916171674395;0.7484268790654467;[PDGFRA, THBD, CEACAM1, PRKCD, CD9, PDGFA]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, PCNA, C5AR1, ATIC, HMOX1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, EZH2]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, ANXA1, FN1, F13A1, THBS1, DCN, SPOCK3]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144B, PLK2, CAV1, PLK1]
GO:0034976;response to endoplasmic reticulum stress;4.0;0.6799073451904818;0.5899536725952409;8.284789505791027;28.997869804256865;4.300610075748959;9.705326059599744E-4;0.4699333992726228;[TLN1, ATF3, JUN, WFS1, TNFRSF10B, EIF2S1, FKBP14, PPP1R15A, THBS1, CCL2, PSMC6, PSMC2]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, PRKCD, PDGFA, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0070509;calcium ion import;9.0;0.8259837884571596;0.8092325194088689;9.36615998802463;37.619827487335996;6.088194173566533;0.0012591017703544919;0.7075911583464645;[CACNA1F, SLC8A1]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, CD28, CD24, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, DCC, PAWR, TNFRSF1B, SIRT1, IFNG, IL1B, TLR4, PPP1R15A, BCL2A1, IFI6, E2F1, E2F2, SORT1, G0S2, MLH1]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCD, VAV1, FGR, HCK, CLEC4D, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0044332;Wnt signaling pathway involved in dorsal/ventral axis specification;8.0;1.0;0.875;9.628524252492122;31.415129658942366;7.9853141584524145;0.0010514361179036673;0.7833693374183408;[FZD5, EGF]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B]
GO:0007354;zygotic determination of anterior/posterior axis, embryo;6.0;1.0;0.8231203125901445;9.628524252492122;41.01780337135347;9.777073627680469;0.001372828965212802;0.8231203125901445;[PCSK6]
GO:0045785;positive regulation of cell adhesion;4.0;0.5768751454443798;0.53843757272219;7.230628979693751;21.972203539282862;3.842179432060882;7.353898787604294E-4;0.44648923483520947;[TFRC, LGALS1, MYB, AKT1, TNFSF11, ICOSLG, SFRP2, CCDC80, NINJ1, COL8A1, PRKCQ, HHLA2, GATA3, CD1D, EPB41L5, KLRK1, NCKAP1L, ICOS, ELANE, LYN, EGR3, JUP, TNFSF14, FN1, AZU1, VNN1, CD28, CD24, NRP1, CD3E, CTLA4, CCR7, CD36, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, VAV1, CEACAM6, IL1B, PTAFR, PAK1, HLA-DMB, PDPN, FLNA, CCL19, IL12RB1, CCL21, LILRB1, LILRB2, CD40LG, HLA-DPB1, CD86, CD83, CD80, SIRPG, CXCL13, TNF, PYCARD, GRAP2, IL6R, TPM1, OLFM4, ADAM9, CARD11, CD274, BLM, CORO1A, DPP4, BTLA, NLRP3, TGFB2, TGFB1, VCAM1, CAV1, IL6, CXCL12, PTPRC, NR4A3, BCL6, DOCK5, SIRPB1, CYR61, TNFSF13B, DUSP10, EMILIN2, EMILIN1, ITGA4, DNM2, ZAP70, IFNG, MMRN1, LCK, XCL1, NOD2, HSPD1, CCL5, CCL2, FYN, CSK, CD4, CD6, DNAJA3, PTPN6, TEK]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, EIF2S1, CXCL10]
GO:0010757;negative regulation of plasminogen activation;10.0;1.0;0.9152410118609203;9.628524252492122;820.5340776865997;7.9853141584524145;0.027462537147443688;0.8236103492792612;[CTSZ, SERPINE1, THBS1]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, CD3E, ZAP70, CD28, XCL1, CCR2]
GO:0001921;positive regulation of receptor recycling;6.0;1.0;0.8231203125901445;9.628524252492122;202.5973984952176;7.138016298065211;0.006780752601813882;0.6881587980249038;[ARAP1, SNCA]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, IL1RN, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, LTA, SAMHD1, NCAM1, CD4, LTBR]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, INPP5D, TLR4, LTF]
GO:0010512;negative regulation of phosphatidylinositol biosynthetic process;10.0;0.8933024483968273;0.861892236059334;9.55953138100517;796.5749339123786;9.083926447120524;0.026660646167149988;0.8797934328124444;[PDGFA]
GO:0010754;negative regulation of cGMP-mediated signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;9.777073627680469;0.008005804360164796;0.875;[THBS1]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0086064;cell communication by electrical coupling involved in cardiac conduction;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;22.009319849728328;7.138016298065211;7.366321282685284E-4;0.6150384854347593;[GJC1, FKBP1B, ATP1B2, ATP1B1, SLC8A1]
GO:0019227;neuronal action potential propagation;6.0;1.0;0.8231203125901445;9.628524252492122;26.361698197207048;7.8311634786251565;8.823023146724341E-4;0.7236063770733796;[FKBP1B, SCN1A]
GO:0010751;negative regulation of nitric oxide mediated signal transduction;8.0;1.0;0.875;9.628524252492122;239.1998693179246;8.67846133901236;0.008005804360164796;0.8188169164668168;[THBS1]
GO:0090201;negative regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.8116675549172;6.943860283624253;0.015824581010188264;0.7513499630073597;[AKT1, CLU]
GO:0006032;chitin catabolic process;7.0;0.811012628672052;0.7564256795932265;9.474373572664863;407.1521334841612;7.8311634786251565;0.013627015494584295;0.7514054297404357;[CHIT1, CHI3L2, CHI3L1]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[ARID4A, BCL6, NCKAP1L, RHAG]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, LY96, CD14, CARD9, NFKB1, NFKBIA]
GO:0007006;mitochondrial membrane organization;5.0;0.6763753087927167;0.6284286662572787;8.578702127993445;39.09948622157772;4.981283082083729;0.0013086246165831567;0.5449840603320351;[CHCHD3, YWHAH, ATP5J2, TFDP1, ATP5J, ATP5I, ATP5H, ATP5O, ATP5L, TP53BP2, E2F1, SFN, SNCA]
GO:0043380;regulation of memory T cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;172.8848963572363;7.697632086000634;0.005786301894771495;0.7898978880348613;[BCL6, IL12RB1]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKCD, PRKAR1B, ATF3, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FN1, FZD8, CDC6, AZU1, NR2F2, NOX4, PKIG, EZH2, CDKN1A, LRRC4, TIMP2, TIMP3, HAVCR2, DUSP2, GPR37, DUSP1, FCRL3, SIRT1, DUSP6, HBEGF, ENG, CCL13, LRRC19, PTGS2, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CARD9, GTF2H1, ELP4, CENPE, PKN1, CCNT2, FMR1, TNF, CLU, CTGF, PYCARD, MEN1, IFNA14, MAP2K2, IFNA16, F2R, CDC25A, ADCYAP1, ADAM9, IFNA10, CSF1R, BLM, TNFRSF11A, PKMYT1, FOXO1, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, COPS5, PTPRC, PLXNB2, CSPG4, LAT, LRRK2, ITGB3, ITGB2, TREM2, PTPN22, CYR61, HHEX, DUSP10, EMILIN1, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, KLF4, RAD50, PTPN6, FCGR2B, PPIL4, IL1RN, CCNH, TCL1A, EDNRB, PPP2R1A, TNFSF11, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EREG, SFRP2, EPHA3, EPHA2, TGFA, TWIST1, PKHD1, CCR1, EGR1, LIF, PTK2, BST1, MARCO, ID1, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, CD40, IFNA2, CD3E, IFNA8, RAC2, CCR7, CD36, MAP4K1, SYK, GP1BA, CEACAM1, MDFIC, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, GNAI2, PAK1, PODN, NLRP12, CD40LG, CD80, IL6R, PDGFRB, PDGFRA, TSC2, HGS, CCNE1, CALCA, C5AR1, FBLN1, ADRB2, HRH4, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, IRAK3, AXIN2, MMP9, DCN, FGR, CCNA2, PSRC1, IFNG, NDUFS4, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, PPP2R1A, AKT1, PAQR3, PRKCD, SFRP2, PRKAR1B, ATF3, TWIST1, FLRT2, PRKAR2B, SFN, LYN, JUN, PLK1, LIF, NR2F2, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP1, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, NTF3, DMD, CDKN2C, PODN, NLRP12, PKN1, PYCARD, MEN1, TSC2, FBLN1, FOXO1, TGFB1, CAV1, PTPRC, LRRK2, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, IRAK3, DCN, CSK, SNCA, KLF4, PTPN6]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[FCER1G, PRKCD, EXO1, INPP5D, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:0032410;negative regulation of transporter activity;6.0;0.6324783794010864;0.6393595022906877;8.124446855715847;47.261139029285694;5.433268205826786;0.0015817877910464942;0.6009779013089371;[, KCNE3, FMR1, TWIST1, PLN, DRD4, SNCA, NDFIP2, CAV1, MMP9, GEM, FKBP1B, GOPC]
GO:0002903;negative regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;155.02018656046687;7.292166977892469;0.00518838613506862;0.7881627702307852;[BCL6, MIF, AURKB]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0001937;negative regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.36028873802138;6.193554689224359;0.002923870244906099;0.6676580400938822;[MEF2C, SPARC, CAV2, CAV1, PRL, NR2F2, TNF, THBS1, CCL2]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[ABCA1, NR1H2, ITGB3, TNF, NFKBIA, IL6]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, AKT1, HMOX1, PLCG1, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0017038;protein import;8.0;0.7436939687323844;0.7468469843661922;8.977936686350972;57.348299591639034;4.842599694549778;0.0019193959772133386;0.6226507735831915;[NUP107, CSE1L, CLU, NUP62, LAMP2, NUP133, SYK, TSC2, MMP12, NUP54, HSPD1, NUP85, NUP88, RANBP2, RANBP1, NUP155, NUP35, RAN]
GO:0010881;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;11.0;1.0;0.9324289523296623;9.628524252492122;219.4584201917244;6.8867018697843045;0.007345075824061613;0.7846152062148197;[PLN, FKBP1B, DMD, SLC8A1]
GO:0055117;regulation of cardiac muscle contraction;8.0;0.6913464685778243;0.7206732342889122;9.097896001429952;36.96524051372258;5.54296712308321;0.00123719333343768;0.6584675964488075;[KCNE3, SLC8A1, CTGF, PLN, PDE4B, FLNA, DMD, DSP, JUP, CAV1, ATP1B1, EHD3, KCNQ1, FKBP1B, PDE5A]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, AKT1, THBS1, SLC8A1]
GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;188.1075192762445;7.212124270218933;0.006295789384399518;0.7197477358342742;[PTGIR, MYOCD, LRP1, HGS, SNCA]
GO:0033623;regulation of integrin activation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;31.007131762763535;7.474488534686424;0.0010377807954928295;0.7053660038532718;[SELP, CXCL13]
GO:0033622;integrin activation;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;7.57984905034425;0.0013529121422039536;0.6778748447945537;[CXCL12, FN1, TLN1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, GAS1, PPP1R15A, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, FAP, JMY]
GO:1903285;positive regulation of hydrogen peroxide catabolic process;8.0;1.0;0.875;9.628524252492122;565.2094731881521;9.083926447120524;0.01891705241210629;0.839552420951524;[SNCA]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[EGF, PDGFC, ADRB2]
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;298.26786127592857;7.004484905440688;0.00998275689325772;0.7091290490632969;[GATA3, THBS1, SULF2]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, THBS1, CCL5, IL6, LIN28A, CD28, EIF3E, EIF3D]
GO:1903284;positive regulation of glutathione peroxidase activity;7.0;1.0;0.8509193652572005;9.628524252492122;224.73580921301883;9.777073627680469;0.0075217052852625714;0.8509193652572005;[SNCA]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[IL1RN, ANXA1, ADCYAP1, FKBP1B]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, CD24]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, KIF16B, FES, HBEGF]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2, SNCA]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, NUP62, SH2B1, PDGFRB, RANBP2, RANBP1, TGFB1, EGF, UBE2C, EREG, BTC, IL1B, CD28]
GO:0000413;protein peptidyl-prolyl isomerization;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;156.19170532668662;6.039404009397101;0.005227595813875556;0.705096027081865;[RANBP2, FKBP14, FKBP1B, PPIL4, FKBP3]
GO:0051048;negative regulation of secretion;6.0;0.5318528234273745;0.5890467243038318;7.102795608183866;46.36667726786087;4.478756261132433;0.001551850960854928;0.552164116067923;[IL1RN, FMR1, TNF, IL13RA2, GHSR, IL1R2, F2R, NLRP3, HMOX1, DRD4, CYP4F2, LIF, FN1, INHBA, IFNA2, PTPN22, LRRC32, CD34, CCR2, ANXA1, RAB33B, CEACAM1, BANK1, IL1B, TLR8, TLR6, GNAI2, CNR1, SNCA, EGF, LILRB1, NLRP12, FKBP1B, FCGR2B, LGR4]
GO:0010459;negative regulation of heart rate;8.0;0.8653626801206646;0.8076813400603323;9.420884887713877;94.46193606230283;7.474488534686424;0.0031615559897821507;0.7572456912631272;[PLN, FKBP1B]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, DUSP1, CAD, NASP]
GO:0032369;negative regulation of lipid transport;6.0;0.6281612110245125;0.6372009181024008;8.242229891372231;82.88956312991112;6.558197802812269;0.0027742390821944756;0.6585068532133508;[EGF, NR1H2, CYP4F2, ITGB3, THBS1, NFKB1, AKT1]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, LGALS1, BLNK, TPD52, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, VCAM1, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0033572;transferrin transport;10.0;1.0;0.9152410118609203;9.628524252492122;96.80640656383476;6.193554689224359;0.0032400233075819585;0.731979686697602;[TFRC, DNM2, TF]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, CHUK, SYK, MMP12, TLR8, TLR7, TLR4, TLR2, HSPD1, CD14, NFKB1, MYD88]
GO:0043310;negative regulation of eosinophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;799.855227739827;9.777073627680469;0.02677043464948191;0.9324289523296623;[CCR2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, EDNRB, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, EREG, POR, ADCY9, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, HHEX, TIMP1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CDKN1A, MYOCD, CDKN2C, PLK1, TNFAIP3, NR2F2, HHEX, MEN1]
GO:0001881;receptor recycling;6.0;0.8436909121759173;0.7449657686781032;9.223059144383958;34.80127764040325;7.379178354882098;0.0011647674435078296;0.7004918368257019;[EHD3]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, CD36, FCGR1B, FCER1G, CHUK]
GO:0014829;vascular smooth muscle contraction;9.0;0.8653626801206646;0.8289219652406215;9.517298617381897;55.68627484309891;7.138016298065211;0.0018637695046048635;0.7612791106150483;[ACTA2, EDNRB, SLC8A1]
GO:0002605;negative regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.710237364246;9.083926447120524;0.0018645715086227877;0.7876727335416686;[FCGR2B, THBS1]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[PNPLA8, MGST1, MIF, PTGS2, PTGS1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, DAPK1, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[LRRK2, TNFAIP3, HHEX, RUVBL1, SOX4, WLS, AXIN2, SFRP4, DEPDC1B, SFRP2, DAAM2, NAIP, TLR2, YAP1, JUP, EGF, CAV1, NFKB1, SULF2, COL1A1, BMP2, LGR4]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CSF1R, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, PTK2, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, DLC1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, GPR15]
GO:0045629;negative regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2589.4439345822343;8.390779266560578;0.08666635814222527;0.8916598066706847;[ANXA1, BCL6]
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;12.0;0.9326813400603323;0.9144609826203107;9.611429819132821;2972.107935112762;7.292166977892469;0.09947377786474029;0.8210420709600095;[EGF, TGFA, EREG]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[EGF, NFKBIA, BCL6]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, SKP2, ESCO2, SPARCL1, SDC2, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, APLP2, FBXW2, PSMD14, CUL5, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, LAMC1, CYR61, LAMB1]
GO:0043691;reverse cholesterol transport;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.943860283624253;0.001326765671179004;0.7301093378270707;[ABCA1, CLU]
GO:0032463;negative regulation of protein homooligomerization;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;148.87198655256626;7.379178354882098;0.004982611413824959;0.7523715242355574;[CLDN7, CLU]
GO:0032464;positive regulation of protein homooligomerization;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;175.26005477141007;7.57984905034425;0.005865796309390097;0.7626338329336335;[BIK, CLU]
GO:0014910;regulation of smooth muscle cell migration;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;40.03709713961528;5.71663061713405;0.0013400056102148314;0.6432681208679463;[DOCK5, NRP1, DOCK4, LRP1, SERPINE1, PDGFA, P2RY6, PAK1, PLAU, CCL5, PDGFD, PDGFRB, MEF2C, MYOCD, ACE, IGFBP5, TPM1, NR4A3, NOX4]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, TLR4]
GO:0022417;protein maturation by protein folding;6.0;1.0;0.8231203125901445;9.628524252492122;59.34513748383371;7.57984905034425;0.001986228344427665;0.710754145523778;[WFS1, FKBP1B]
GO:0009100;glycoprotein metabolic process;5.0;0.6162540371078848;0.5983680304148626;8.375761283996754;94.72373048927207;4.981283082083729;0.0031703180136531234;0.5449840603320351;[PCSK6, NDST3, HS3ST3B1, COL11A1, ADAMTS12, SULF2, BMP2, HPSE]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, NLRP3]
GO:0044546;NLRP3 inflammasome complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;9.777073627680469;0.0014899461700306506;0.8231203125901445;[NLRP3]
GO:0019371;cyclooxygenase pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.379178354882098;0.008476883539459374;0.7926125360964777;[TBXAS1, PTGS2, PTGS1]
GO:0014808;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;16.0;1.0;1.0;9.628524252492122;562.8564541266966;7.8311634786251565;0.01883829898169905;0.9004860644832351;[FKBP1B, CCR5]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[ANXA1, SLC11A1, CD80, XCL1, CCL19, IL12RB1, IL6R, CCR2]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[LILRB1, IRAK3, THBS1, NFKB1, TLR8]
GO:0002829;negative regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.78588677179087;7.138016298065211;0.0036409657293100133;0.6881587980249038;[ANXA1, BCL6, ARG1, IFNA2, CCR2]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, PDGFA, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, FZD5, FZD8, CDC6, NOX4, CD24, EZH2, CD40, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD40LG, PKN1, CCNT2, TNF, PDGFRB, MAP2K2, F2R, ADAM9, CSF1R, C5AR1, TNFRSF11A, ADRB2, DRD4, MAP2K6, TGFB1, GH1, BMP2, CSPG4, LRRK2, GHR, PSRC1, IFNG, PDE5A, LTF, NOD2, THBS1, CSK, SNCA, EGF, MAPK14]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[F11R, TNF, ANTXR1, AQP1, MYOZ2, PDGFRB, MEF2A, PDGFRA, GAS2L3, CXADR, TPM1, DAAM2, TLN1, PFN1, LLGL2, PDGFA, CORO1A, EPB41L5, CNN1, RACGAP1, EPB41L3, MYH14, MYH11, NCKAP1L, MYH10, CORO2A, TBCK, BCL6, NRP1, ITGB5, LMOD1, ARHGEF10L, CXCL1, ANXA1, RHOG, GAB1, RHOH, PALLD, KIT, RHOU, FGD3, FGD4, PAK1, ABLIM3, FLNA, SORBS1, KRT19, DLC1, ZYX]
GO:0032456;endocytic recycling;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.979792040619635;6.409777797693995;0.0016393095606485504;0.6509166472493662;[DENND1B, EHD3]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, NOD2, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0007097;nuclear migration;5.0;0.7140352122741334;0.6472586179979869;8.712233520617966;66.0178211805495;6.781341354126479;0.002209557062731295;0.6370391240755715;[HHEX, MYH10, PTK2]
GO:0008064;regulation of actin polymerization or depolymerization;9.0;0.6729672293956388;0.7327242398781084;9.05316010758856;119.88573797499163;4.556717802602145;0.004012467759863614;0.6292713855144111;[CYFIP1, PYCARD, EPS8, ARFIP1, PRKCD, PFN1, CORO1A, SPTA1, NCKAP1L, VASP, CXCL12, JMY, LMOD1, CCR7, SPTAN1, CIT, HCK, EPS8L1, GSN, CCL21]
GO:0045124;regulation of bone resorption;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;23.47587490287836;6.139487467954083;7.857164060836016E-4;0.6370939872166814;[CSF1R, CALCA, TFRC, SYK, ITGB3, TNFAIP3, TNFRSF11A, TMEM64, IL6, INPP5D, TNFSF11, CSK]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, PHB2, HOXA11, HHEX, HOXA5, PAX2, SFRP2, COL4A1, ENG, EPHA2, PAK1, TGFB1, EGF, VDR, PPP1CA, BMP2]
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;662.774530299232;7.069023426578259;0.02218246707076338;0.7939391391080821;[KLF4, THBS1]
GO:1902957;negative regulation of mitochondrial electron transport, NADH to ubiquinone;13.0;1.0;0.9625549647676366;9.628524252492122;1582.933473614211;9.777073627680469;0.052979358814230854;0.9625549647676366;[SNCA]
GO:0060402;calcium ion transport into cytosol;12.0;0.7586651285174919;0.8274528768488905;9.456673995565463;341.89307646082915;5.6339389012889365;0.01144285358535166;0.7362402100070131;[CCL21, F2R, FASLG, SLC8A1, JPH2, PTPRC, LCK, FKBP1B, XCL1, CCR7, CCL19, CCR5]
GO:1902949;positive regulation of tau-protein kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1259.196440836814;7.9853141584524145;0.04214417167158519;0.8407982897480031;[EGR1, CLU]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, AQP1, PLAU, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, SUV39H1, ALAD, MYOCD, ADSL, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, E2F1, TEK]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0002634;regulation of germinal center formation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;44.47967864407596;7.57984905034425;0.0014886948151053528;0.738553198190834;[MEF2C, BCL6, TNFAIP3, PKN1, TNFSF13B]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[ORM1, LRRK2, PTPN22, TNF, PYCARD, CLEC5A, FFAR2, CD34, HAVCR2, CHUK, SYK, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, NLRP3, CD58, CCL19, CD14, FZD5, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0050713;negative regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;7.379178354882098;0.033445798446087804;0.8098004765652196;[NLRP3]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[TNF, PYCARD, CLEC5A, SOX4, WLS, F2R, GOLPH3L, MIF, ADAM9, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, IL6, ORM1, LRRK2, PTPN22, FFAR2, CD34, HAVCR2, CHUK, SYK, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, NOD2, CD58, CCL19, NR1H2, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, IL6, LTA, MYD88, TLR2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6]
GO:0035793;positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;462.90611455550015;8.67846133901236;0.015493051065716704;0.8762458687964789;[PDGFRB, PDGFA]
GO:0032286;central nervous system myelin maintenance;6.0;1.0;0.8231203125901445;9.628524252492122;21.34652774794371;8.390779266560578;7.144490730959624E-4;0.7522251544931926;[CLU]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL17RB, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, TLR6, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, CNR1, CCL4, S100A12, CCL18, SNCA, CCL23, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:1902847;regulation of neuronal signal transduction;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;9.777073627680469;0.0014007232725606145;0.8231203125901445;[CLU]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR2]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[FCER1G]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCR1, CXCR1, CCL21, CCL5, CXCR2, CXCR4, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:0030099;myeloid cell differentiation;4.0;0.6913464685778243;0.5956732342889122;8.146919711567906;21.066225782797595;4.720827822332161;7.050676185779127E-4;0.49142335437501145;[SPI1, TFRC, TNF, CLEC5A, TNFSF11, MEF2C, ACTN1, OSCAR, PRTN3, HOXB7, TRIM10, EPHA2, CSF1R, TNFRSF11A, GATA3, RASGRP4, NKX2-3, LYN, JUN, TGFB1, NBEAL2, INHBA, TREM2, HHEX, CCR7, FCER1G, MMP9, SIRT1, CBFA2T3, TGFBR3, KIT, CEBPE, CCL19, MAPK14, KLF1, CAMK4, ACIN1, PTPN6, LTBR]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, S100A12, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CLU, CDH5, IGHG1, GHSR, ADCYAP1, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, CD6, TEK, FCGR2B]
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;71.50580126066325;7.379178354882098;0.0023932348171512878;0.7004918368257019;[CXCL12, FYN, SCN1A]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CALCA, CXCL12, EPHB1]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, TLR6, CD14, TLR4]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0007194;negative regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6285.124034700197;6.481236761676141;0.21035744519701882;0.7795710619905949;[P2RY13, GABBR1, EDNRB, GPR87, HRH4, GNAI2, CCR2]
GO:0031065;positive regulation of histone deacetylation;10.0;0.8933024483968273;0.861892236059334;9.571365838652174;1219.9035963218012;6.8867018697843045;0.04082907552693193;0.7674272657460779;[TGFB1, LRRK2, BCL6]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, SPINT2, PHB2, CYP1B1, EPHB1, SOX7, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, HMOX1, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, LRRC32, TIMP2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, IGFBP5, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, TFDP1, IFNG, LTA, XCL1, PDE5A, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IGFBP5, MMP2, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CD80, PPP2R1A, IL6R, PRKCD, MIF, EREG, SFRP2, CSF1R, TGFA, PDGFA, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, CD3E, GHR, GRM5, CD36, SYK, IFNG, BANK1, KIT, HBEGF, CCL5, NTF3, FYN, EGF, CD4, PTPN6]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGA4, ITGB3, FN1, LAMB1, LAMC1, ANTXR1, ITGB7, TEK]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, FASLG, PHB2, SLC8A1, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, F2R, CACNA2D3, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, CUL5, ATP2C2, CACNA1F, CCL19, CCL21, PTPRC, FKBP1B]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKAR2B, PDGFC, NCKAP1L, ECT2, DRD4, MAP2K6, TGFB2, TNFRSF10B, BMP2, CSPG4, LRRK2, ITGB3, GHR, MAP4K1, SYK, DUSP6, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:0071313;cellular response to caffeine;7.0;1.0;0.8509193652572005;9.628524252492122;615.975441994369;7.697632086000634;0.02061614370164466;0.7445766281117727;[SLC8A1]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[NRP1, NRP2, CD40, SPARC, ITGB3, AKT1, ANXA1, ANXA3, SIRT1, GATA3, PTGS2, THBS1, HMOX1, PLCG1, TGFB1, PLK2, TEK]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, EREG, IFNG, BANK1, KIT, HBEGF, CSF1R, TGFA, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[BCL6, PLK2, TWIST1, SLC30A10, SIRT1]
GO:0033591;response to L-ascorbic acid;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;69.44758579076571;7.9853141584524145;0.0023243481976474804;0.7592887026755414;[SPARC, IL1B]
GO:0061740;protein targeting to lysosome involved in chaperone-mediated autophagy;12.0;1.0;0.9481203125901445;9.628524252492122;450.1958901409887;8.67846133901236;0.01506765129302233;0.8919372290569614;[LAMP2, CLU]
GO:0061741;chaperone-mediated protein transport involved in chaperone-mediated autophagy;9.0;1.0;0.896240625180289;9.628524252492122;132.03373909148056;9.083926447120524;0.0044190504247412915;0.8607930461318132;[CLU]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, TTC7B, EREG, BTC, CSF1R, PDGFA, CD19, INPP5D, ICOS, BMX, CD28, IMPA2, GAB1, VAV1, LCK, KIT, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG]
GO:0090160;Golgi to lysosome transport;8.0;1.0;0.875;9.628524252492122;114.4124755644324;7.697632086000634;0.0038292825925985686;0.7686572628545723;[EHD3]
GO:0090280;positive regulation of calcium ion import;9.0;0.8653626801206646;0.8289219652406215;9.420884887713877;92.69484377077161;6.8867018697843045;0.0031024130010644134;0.7484268790654467;[PDGFRB, LGALS3, CXCL12, CCL2]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, JUN, ITGAM, ITGB2, TLR8, TLR7, FPR2, AZU1, TLR6, CLU, TLR2, SNCA]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:0050748;negative regulation of lipoprotein metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.474373572664863;288.58086877261815;8.390779266560578;0.00965854197189917;0.7800242071602487;[ITGB3]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[UNC93B1, TLR7, HAVCR2]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, VRK1, MELK, BTK, SIK1, BLK, CSF1R, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0060603;mammary gland duct morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.20947323359611;8.16763571524637;0.0010780220824845236;0.7408135829017477;[CSF1R]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, KLF4, MMP9, IFNG]
GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.417215158824915;234.05310184950287;6.113511981550823;0.00783354668478672;0.6876452870438905;[NUP62, EGF, HGS]
GO:0090370;negative regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.35455179279643;8.390779266560578;0.006170180940179963;0.8253454670833372;[EGF]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:2000439;positive regulation of monocyte extravasation;10.0;1.0;0.9152410118609203;9.628524252492122;703.5203275945537;9.083926447120524;0.023546192237400974;0.8797934328124444;[PDGFD, CCR2]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, HAVCR2, SNCA, MIF, BPI, TLR6, FCGR2B, TLR4, CD200]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[AQP1, RPS6KA1, AKT1, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0055003;cardiac myofibril assembly;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;125.46400130584401;6.641579411751319;0.0041991672134361795;0.7146506799819907;[PDGFRB, MEF2A, PDGFRA, MYH10]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A8, NLRC4, HSPD1, NLRP3, SNCA, TNFRSF10B, HSPE1, NLRP12, P2RX1, DLC1]
GO:0016973;poly(A)+ mRNA export from nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;122.0533615230405;7.004484905440688;0.004085016169282269;0.7734506956670166;[HHEX]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, NLRP3, XCL1, GATA3]
GO:0071727;cellular response to triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.67846133901236;0.005649674571872418;0.8188169164668168;[TLR1, CD14, TLR2]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, CYP1B1, HAVCR2, CHUK, IRAK3, SIRT1, PKHD1, NLRP3, KLF4, NFKBIA, NLRP12, CCDC22]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:0090265;positive regulation of immune complex clearance by monocytes and macrophages;6.0;1.0;0.8231203125901445;9.628524252492122;55.8946973761224;9.777073627680469;0.0018707452192170582;0.8231203125901445;[CCR2]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, ITGB2, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[LRP1, ITGB3, MARCO, CD36]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0046425;regulation of JAK-STAT cascade;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;46.16872612457469;4.77312732173501;0.0015452257142336023;0.6190979532066485;[IFNA5, IFNA4, IFNA7, CD40, IFNA2, LRRC4, PRL, IFNA8, GHR, PPP2R1A, LRRTM4, CYP1B1, IL6R, IFNA14, IFNA16, F2R, GP1BA, DCN, IFNG, HGS, KIT, IFNA10, CSF1R, LRRC19, FLRT2, CCL5, FYN, IFNA21, LYN, EGF, CAV1, LIF, PODN, GH1, IL6]
GO:0048842;positive regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2927.4139206492227;7.8311634786251565;0.09797790942264722;0.8486063770733797;[NRP1, CXCL12]
GO:0006930;substrate-dependent cell migration, cell extension;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[NRP1, MYH10]
GO:0002573;myeloid leukocyte differentiation;5.0;0.7369933605727446;0.6587376921472925;8.741221057491218;45.128183839147766;5.311165509025885;0.0015103997003676221;0.5618542629869587;[SPI1, TFRC, TREM2, TNF, HHEX, TNFSF11, CCR7, MEF2C, FCER1G, MMP9, SIRT1, CBFA2T3, OSCAR, KIT, PRTN3, EPHA2, CSF1R, CEBPE, TNFRSF11A, GATA3, CCL19, NKX2-3, JUN, TGFB1, MAPK14, CAMK4, LTBR]
GO:0045217;cell-cell junction maintenance;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;51.610367046990525;7.474488534686424;0.0017273525387479806;0.6724867031240476;[CSF1R, F2R, PRTN3, CD177]
GO:0002687;positive regulation of leukocyte migration;8.0;0.6634067003016617;0.7067033501508309;8.963547948898873;238.70113796770806;4.956792062075433;0.007989112270702124;0.6284905765689417;[CXCL6, CXCL9, ITGA2B, SERPINE1, CXCL1, CXCL13, CXCL3, CXCL2, TNF, CXCL5, PYCARD, LGALS3, C3AR1, RAC2, CCR7, CCR6, IL6R, CCR2, ITGA4, IL1R1, IL1B, XCL1, C5AR1, PTAFR, FPR2, PLA2G7, THBS1, CCL8, CCL7, CCL5, PDGFD, CXCR2, CCL4, CCL1, NCKAP1L, CCL19, S100A14, ELANE, CCR1, TGFB1, TNFSF14, CCL21, CCL20, PPBP, MAPK14, SELP, CXCL10, CXCL11, IL6, CXCL12, PF4]
GO:0055013;cardiac muscle cell development;6.0;0.811012628672052;0.7286266269261705;9.186691500213083;68.17761422754299;6.139487467954083;0.0022818433923266195;0.6370939872166814;[CXADR, MYH11, MYH10, SLC8A1]
GO:2000321;positive regulation of T-helper 17 cell differentiation;13.0;0.9326813400603323;0.9288956347978027;9.611994950540911;2604.3016792955605;7.697632086000634;0.08716363348667819;0.8562122276222088;[NLRP3, IL12RB1]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[MYH10]
GO:0034498;early endosome to Golgi transport;7.0;1.0;0.8509193652572005;9.628524252492122;101.51493214272642;7.57984905034425;0.0033976134213095565;0.738553198190834;[EHD3]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, CD14, TLR2]
GO:0035584;calcium-mediated signaling using intracellular calcium source;8.0;1.0;0.875;9.628524252492122;30.117246255164275;6.781341354126479;0.0010079971283984438;0.7217981122146513;[SELP, GRM5, VCAM1, CCL20, FKBP1B, AZU1]
GO:0022029;telencephalon cell migration;6.0;0.6873818243518346;0.6668112247660618;8.68406264365127;21.32120993996455;6.250713103064308;7.136017088474478E-4;0.6427820713687392;[CX3CR1, NRP1, LRRK2, CXCL12, TNR]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[YAP1, GJC1, TMEM100, HHEX, MYOCD, TGFB1, CAV1, TIE1, PTK2, TGFBR3, ENG]
GO:0022027;interkinetic nuclear migration;6.0;1.0;0.8231203125901445;9.628524252492122;68.32040627354414;7.9853141584524145;0.0022866225136017795;0.7314896500084853;[HHEX]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, AURKB, SNCA, MEIS2]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, DUSP10, BCL6, IFNG, LILRB2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[SPI1, SPARC, TNC, EEF1B2, ALAD, ADCYAP1, CLDN3, IL1B, CLDN7, S100A8, PSMD14, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1]
GO:0071872;cellular response to epinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;7.212124270218933;0.01373211325256535;0.7438283705770736;[KCNQ1, PDE4B, SNCA]
GO:0050812;regulation of acyl-CoA biosynthetic process;7.0;0.8436909121759173;0.7727648213451592;9.466005322994347;197.71914732637842;7.57984905034425;0.006617481925333854;0.738553198190834;[SNCA]
GO:2000451;positive regulation of CD8-positive, alpha-beta T cell extravasation;12.0;0.8933024483968273;0.8947715367885583;9.55953138100517;875.6996893704704;9.083926447120524;0.029308880524675604;0.9126727335416687;[CCR2]
GO:0072606;interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.390779266560578;0.004587596526932657;0.8443458537639685;[CHI3L1]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, CD14, TLR4]
GO:0050930;induction of positive chemotaxis;8.0;1.0;0.875;9.628524252492122;129.39753142075796;7.138016298065211;0.004330818926435078;0.7400384854347593;[CXCL12, NTF3, AZU1]
GO:0051918;negative regulation of fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;332.9628274369728;7.474488534686424;0.011143966187225523;0.7784863164434164;[THBD, SERPINE1, THBS1]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, BPI, TLR4, LTF]
GO:0033033;negative regulation of myeloid cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.360260265897443;105.01969455662797;7.069023426578259;0.003514914665221449;0.7365101867784198;[GHSR, FCER1G, CCL5, CXCR2, CLEC5A, MIF, NOD2, CCR5]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, PDGFA, GATA3, FN1, DUSP2, DUSP1, DUSP6, IL12RB2, PKN1, EFEMP1, KCNH1, KCNH2, FBXW2, CDC25A, BLK, PKMYT1, NAE1, BMX, HM13, IL2RG, EIF4H, FYN, IL2RB, EIF3F, CDC20, C1GALT1C1, LGALS1, TNFSF11, SNRPD3, ALG8, BTC, BTK, NAIP, SDC2, EGR2, PTK2, MUC15, SPTAN1, SYK, RNF144B, IL1B, KIT, PCNA, KITLG, NDUFAB1, BUB1B, LOXL2, UBE2C, UBE2M, TNFAIP3, GHR, CAD, IRAK3, SHANK3, SPOCK3, TEK, PRKCD, HMBS, PRKCQ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, PLK1, ASGR1, ASGR2, TIMP1, CIT, GSN, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, MAP2K6, COPS5, P4HA2, CCDC22, LAT, GAL3ST1, CYR61, LCK, TPTE, NLRC4, NOD2, TTR, CSK, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, LIF, PRL, ZDHHC17, HCK, TLR7, TLR4, TLR2, QPCT, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, THBS1, BUB1, SNCA, WEE1, EHMT2, MYLK, KRTCAP2, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, IQGAP3, LYN, ABCA1, HACE1, LYZ, EZH2, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A8, FOXO1, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, UTY, DSP, PPP1R12A, BIRC5, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, CCNH, EPHB1, PAQR3, EREG, ALPK2, EPHA3, EPHA2, TF, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP4, SPTA1, CLK4, CLK1, IL6, BMP2, LAMC1, MMP1, MMP2, CCNA2, TAF9, AURKB, GALNT7, GALNT6, EGF, LAMB1, MAPK14, TAF5, DAPK1, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, IGFBP5, MELK, CSF1R, CUL5, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, PTPN22, DUSP10, CHUK, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, SGK1, RANBP2, CAMK4, GALNT14, ARID4A, ARID4B, FBL, APLP2, CSF2RB, ADRB2, TGFB2, TGFB1, NFKBIA, FES, TGFBR3, FGR, EHHADH, NCAM1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[LHCGR, PTAFR, CD244, SNCA]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0002674;negative regulation of acute inflammatory response;8.0;0.7369933605727446;0.7434966802863723;9.132087366178231;164.84175655116067;7.292166977892469;0.005517105243818016;0.747921758369865;[ADCYAP1, NLRP3, FCGR2B]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, S100A12, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[F2R, FLT3LG, CORO1A, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, MAD2L1, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, CD40, CTSZ, CTSH, VAV1, IL1B, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, YWHAH, MMP9, DNM2, IFNG, LTA, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[CD151, FYN, TNFSF14, SLC11A1, LILRB1, FKBP1B]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, NCF4, ICAM3, ITGAL, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, MARCO]
GO:2000464;positive regulation of astrocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;839.0762499551136;9.777073627680469;0.028083126966399207;0.9152410118609203;[CCR2]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, ANXA1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, PCNA, SNCA, KLF4]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, NLRC4, CD36, TLR6, TLR4]
GO:0050701;interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.523163736834295;137.06961104194002;7.474488534686424;0.004587596526932657;0.7974867031240476;[ABCA1, NLRP3, NLRC4, CD36, TLR6, TLR4]
